Insulin sensitisation as a novel mechanism to lessen ischaemic burden in overweight non-diabetic patients with chronic stable angina: a pilot study
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2009
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 18 Feb 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.